The total number of records retrieved from this search are 12. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_328	Virus nameAdenovirus	Virus strainAdhz60	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationE1b-deleted mutant	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH441	Concentration of cell line2.5E+4 cells per well	In-vitro toxicityNA	AssayCrystal violet staining	In-vitro virus concentration1 MOI	In-vitro result1% cancer cell death	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26561948
IDOV_332	Virus nameAdenovirus	Virus strainAdhz60	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationE1b-deleted mutant	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH441	Concentration of cell line2.5E+4 cells per well	In-vitro toxicityNA	AssayCrystal violet staining	In-vitro virus concentration2.5 MOI	In-vitro result1% cancer cell death	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26561948
IDOV_336	Virus nameAdenovirus	Virus strainAdhz60	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationE1b-deleted mutant	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH441	Concentration of cell line2.5E+4 cells per well	In-vitro toxicityNA	AssayCrystal violet staining	In-vitro virus concentration5 MOI	In-vitro result1% cancer cell death	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26561948
IDOV_340	Virus nameAdenovirus	Virus strainAdhz60	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationE1b-deleted mutant	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH441	Concentration of cell line2.5E+4 cells per well	In-vitro toxicityNA	AssayCrystal violet staining	In-vitro virus concentration10 MOI	In-vitro result2% cancer cell death	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26561948
IDOV_344	Virus nameAdenovirus	Virus strainAdhz60	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationE1b-deleted mutant	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH441	Concentration of cell line2.5E+4 cells per well	In-vitro toxicityNA	AssayCrystal violet staining	In-vitro virus concentration20 MOI	In-vitro result45% cancer cell death	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26561948
IDOV_346	Virus nameAdenovirus	Virus strainAdLacZ	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationE1/E3-deleted mutant	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH441	Concentration of cell line2.5E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result62% cancer cell viability	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26561948
IDOV_349	Virus nameAdenovirus	Virus strainAdhz60	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationE1b-deleted mutant	Virus aloneNo	Virus in combination with drug/radiationVirus in combination with temozolomide (TMZ) - 0.75 mM	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH441	Concentration of cell line2.5E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration20 MOI	In-vitro result22% cancer cell viability	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedJNK activation induces autophagy	Immunogenic effectNA	Clinical trialNA	PMID26561948
IDOV_4246	Virus nameMeasles virus	Virus strainrMV-SLAMblind	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationR533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNational institute of biomedical innovation, Japan	Origin of cell lineHuman nonsmall cell lung carcinoma cell line	Cell lineNCI-H441	Concentration of cell line5.0E+3 cells per well	In-vitro toxicityNA	AssayWST-1 assay	In-vitro virus concentration1 MOI	In-vitro result100% cell viability after day 1	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26317644
IDOV_4247	Virus nameMeasles virus	Virus strainrMV-SLAMblind	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationR533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNational institute of biomedical innovation, Japan	Origin of cell lineHuman nonsmall cell lung carcinoma cell line	Cell lineNCI-H441	Concentration of cell line5.0E+3 cells per well	In-vitro toxicityNA	AssayWST-1 assay	In-vitro virus concentration1 MOI	In-vitro result80% cell viability after day 3	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26317644
IDOV_4248	Virus nameMeasles virus	Virus strainrMV-SLAMblind	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationR533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNational institute of biomedical innovation, Japan	Origin of cell lineHuman nonsmall cell lung carcinoma cell line	Cell lineNCI-H441	Concentration of cell line5.0E+3 cells per well	In-vitro toxicityNA	AssayWST-1 assay	In-vitro virus concentration1 MOI	In-vitro result35% cell viability after day 5	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26317644
IDOV_4249	Virus nameMeasles virus	Virus strainrMV-SLAMblind	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationR533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNational institute of biomedical innovation, Japan	Origin of cell lineHuman nonsmall cell lung carcinoma cell line	Cell lineNCI-H441	Concentration of cell line5.0E+3 cells per well	In-vitro toxicityNA	AssayWST-1 assay	In-vitro virus concentration1 MOI	In-vitro result100% cell killing after day 7	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26317644
IDOV_5916	Virus nameMeasles virus	Virus strainwild type	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMutated for SLAM binding	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman lung cancer cell line	Cell lineNCI-H441	Concentration of cell lineNA	In-vitro toxicityNA	AssayWST-1 assay	In-vitro virus concentration1 MOI	In-vitro resultComplete cell killing after 7 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMIDUS10335481